News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
144 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (183)
2 (133)
5 (258)
6 (198)
7 (182)
8 (148)
9 (107)
12 (179)
13 (165)
14 (166)
15 (167)
16 (111)
19 (154)
20 (181)
21 (149)
22 (151)
23 (144)
26 (176)
27 (154)
28 (138)
29 (167)
30 (89)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
Drug Development
Braeburn Pharma Release: Phase II Trial Demonstrates Long-acting Buprenorphine Blocks Opioid Effects and Suppresses Withdrawal Symptoms in Adults with Opioid Use Disorder
June 23, 2017
·
5 min read
Drug Development
BIO2017 CARsgen Therapeutics Presented At The 2017 BIO International Convention
June 23, 2017
·
2 min read
Biotech Bay
European CHMP Adopts Positive Opinion For Gilead’s Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir) For The Treatment Of All Chronic Hepatitis C Genotypes
June 23, 2017
·
4 min read
Drug Development
bluebird bio Presents New Data From HGB-205 Study Of LentiGlobin Drug Product In Patients With Transfusion-Dependent ?-Thalassemia (TDT) And Severe Sickle Cell Disease (SCD) At European Hematology Association Annual Meeting
June 23, 2017
·
10 min read
Genetown
Acceleron Pharma Provides Updated Results From Phase II Studies Of Luspatercept In Beta-Thalassemia At The 22nd Congress Of The European Hematology Association
June 23, 2017
·
8 min read
Drug Development
Syros Pharma Presents Data At EHA Supporting Potential Of SY-1425, Its First-In-Class Selective Rara Agonist, In Genomically Defined AML And MDS Patients
June 23, 2017
·
8 min read
Biogen’s IMRALDI, An Adalimumab Biosimilar Candidate Referencing Humira, Granted Positive Opinion By Committee For Medicinal Products For Human Use
June 23, 2017
·
5 min read
Drug Development
Novartis AG Pivotal CTL019 6-Month Follow-Up Data Show Durable Remission Rates In Children, Young Adults With R/R B-Cell ALL
June 23, 2017
·
11 min read
Pharm Country
Walter Reed National Military Medical Center Acquires A Brainsway Deep TMS System To Enhance Its Treatment Of Depression
June 23, 2017
·
2 min read
Pharm Country
Axim Biotech Files Patent On Controlled Release Chewing Gum To Provide Opioid Addiction Treatment
June 23, 2017
·
4 min read
Previous
13 of 15
Next